司帕沙星治疗解脲尿枝原体性前列腺炎的疗效观察

Clinical observation of sparfloxacin in the treatment of ureaplasma urealyticum prostatitis

目的探索分析司帕沙星治疗解脲尿枝原体性前列腺炎的疗效。方法选取治疗的96例患有解脲尿枝原体性前列腺炎的患者,将其随机分成观察组(n=48例)和对照组(n=48例)。对照组采用氧氟沙星进行治疗,观察组采用司帕沙星进行治疗,分析2组患者治疗后的临床效果。结果观察组总有效率(97.92%)显著高于对照组总有效率(72.92%)(P<0.05);治疗后,观察组的患者发生的总不良反应率(8.33%)与对照组的患者发生的总不良反应率(10.42%)相比,差异无统计学意义。结论对于患有解脲尿枝原体性前列腺炎的患者而言,采用司帕沙星治疗的效果比较显著,不良反应发生率也较低,安全性较高。

Objective To investigate clinical effect of sparfloxacin on the treatment of ureaplasma urealyticum prostatitis. Methods 96 cases with ureaplasma urealyticum prostatitis,which admitted in our hospital,were selected as the research object and divided into observation group（ n = 48cases） and control group（ n = 48 cases） randomly. The control group was given the ofloxacin for treatment and the observation group was given the sparfloxacin for treatment. The clinical effect of the two groups after treatment was analyzed. Results The total effective rate of the observation group（ 97. 92%） was significantly higher than that of the control group（ 72. 92%）（ P〈0. 05）. After treatment,the total incidence of adverse reactions of the observation group（ 8. 33%） compared with that of the control group（ 10. 42%）,had no significant difference（ P〈0. 05）. Conclusion Patients with ureaplasma urealyticum prostatitis,the treatment effect of sparfloxacin is significant,with lower adverse reactions rate and the security is higher,which is recognized in the medical community,can be worthy of popularization and application in clinic.